Sec13 Inhibitors

Sec13 inhibitors, as a chemical class, are not compounds that directly interact with the Sec13 protein itself, but rather influence the protein indirectly by affecting the processes and pathways in which Sec13 is involved. These inhibitors work by disrupting various steps in the secretory pathway, from the formation of the vesicle coat to the transport of vesicles within the cell. The compounds listed can influence the COPII complex indirectly, either by disrupting upstream regulators like Sar1p, which is essential for COPII coat formation, or downstream events like vesicle fusion and cargo sorting which rely on proper COPII function. For instance, Brefeldin A acts on Sec7 domain-containing proteins and can lead to a disruption of the vesicular transport, indirectly affecting the function of Sec13 in the COPII complex.

Additionally, since Sec13 is a part of the cellular machinery that is sensitive to the homeostasis of the endoplasmic reticulum (ER), chemicals like tunicamycin and thapsigargin that induce ER stress also have the capacity to modulate the function of Sec13. ER stress leads to a cascade of events under the unfolded protein response (UPR), which can alter COPII-mediated transport and, consequently, Sec13 activity. The chemicals do not bind directly to Sec13 but instead modify the cellular environment or the activity of closely related proteins and processes, which in turn can alter Sec13's involvement in vesicle trafficking. This modulation can manifest in various ways, from altering the lipid composition critical for vesicle formation to modulating the protein folding environment within the ER, which is critical for proper COPII function.